| VitaeNoctis vs Bryan | 30–27 | 52.63% |
| VitaeNoctis vs Jin | 29–26 | 52.73% |
| VitaeNoctis vs Yoshimitsu | 28–21 | 57.14% |
| VitaeNoctis vs Dragunov | 19–26 | 42.22% |
| VitaeNoctis vs King | 23–21 | 52.27% |
| VitaeNoctis vs Kazuya | 24–20 | 54.55% |
| VitaeNoctis vs Claudio | 18–18 | 50.00% |
| VitaeNoctis vs Lee | 19–17 | 52.78% |
| VitaeNoctis vs Feng | 19–16 | 54.29% |
| VitaeNoctis vs Eddy | 12–22 | 35.29% |
| VitaeNoctis vs Paul | 19–13 | 59.38% |
| VitaeNoctis vs Hwoarang | 14–16 | 46.67% |
| VitaeNoctis vs Devil Jin | 15–15 | 50.00% |
| VitaeNoctis vs Alisa | 13–14 | 48.15% |
| VitaeNoctis vs Azucena | 12–15 | 44.44% |
| VitaeNoctis vs Law | 13–12 | 52.00% |
| VitaeNoctis vs Steve | 12–13 | 48.00% |
| VitaeNoctis vs Victor | 10–13 | 43.48% |
| VitaeNoctis vs Lili | 14–7 | 66.67% |
| VitaeNoctis vs Jun | 4–14 | 22.22% |
| VitaeNoctis vs Shaheen | 5–12 | 29.41% |
| VitaeNoctis vs Zafina | 10–7 | 58.82% |
| VitaeNoctis vs Reina | 11–6 | 64.71% |
| VitaeNoctis vs Xiaoyu | 10–5 | 66.67% |
| VitaeNoctis vs Leo | 9–6 | 60.00% |
| VitaeNoctis vs Asuka | 9–5 | 64.29% |
| VitaeNoctis vs Nina | 10–3 | 76.92% |
| VitaeNoctis vs Jack-8 | 6–6 | 50.00% |
| VitaeNoctis vs Lars | 8–4 | 66.67% |
| VitaeNoctis vs Raven | 7–4 | 63.64% |
| VitaeNoctis vs Kuma | 5–5 | 50.00% |
| VitaeNoctis vs Leroy | 6–1 | 85.71% |
| VitaeNoctis vs Panda | 1–3 | 25.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.